Porter A, Cobbin J, Li C, Eden J, Holmes E
Viruses. 2021; 13(11).
PMID: 34834931
PMC: 8625350.
DOI: 10.3390/v13112122.
Tang Y, Na L, Zhu C, Shen N, Yang F, Fu X
J Virol. 2014; 88(21):12296-310.
PMID: 25122784
PMC: 4248950.
DOI: 10.1128/JVI.01379-14.
Meng Q, Lin Y, Ma J, Ma Y, Zhao L, Li S
Viral Immunol. 2012; 25(6):477-84.
PMID: 23171359
PMC: 3518545.
DOI: 10.1089/vim.2012.0014.
Yuan Q, Liu C, Liang Z, Chen X, Diao D, Kong X
Virol Sin. 2012; 27(4):241-7.
PMID: 22899432
PMC: 8218065.
DOI: 10.1007/s12250-012-3253-x.
Liu L, Wan Y, Wu L, Sun J, Li H, Li H
Retrovirology. 2010; 7:71.
PMID: 20807451
PMC: 2940887.
DOI: 10.1186/1742-4690-7-71.
EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages.
Covaleda L, Fuller F, Payne S
Virology. 2009; 397(1):217-23.
PMID: 19945727
PMC: 2813941.
DOI: 10.1016/j.virol.2009.11.005.
Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.
Zielonka J, Bravo I, Marino D, Conrad E, Perkovic M, Battenberg M
J Virol. 2009; 83(15):7547-59.
PMID: 19458006
PMC: 2708611.
DOI: 10.1128/JVI.00015-09.
Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.
Bogerd H, Tallmadge R, Oaks J, Carpenter S, Cullen B
J Virol. 2008; 82(23):11889-901.
PMID: 18818324
PMC: 2583693.
DOI: 10.1128/JVI.01537-08.
Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
Tallmadge R, Brindley M, Salmans J, Mealey R, Maury W, Carpenter S
Clin Vaccine Immunol. 2008; 15(7):1138-40.
PMID: 18448619
PMC: 2446648.
DOI: 10.1128/CVI.00088-08.
Although macrophage-tropic simian/human immunodeficiency viruses can exhibit a range of pathogenic phenotypes, a majority of isolates induce no clinical disease in immunocompetent macaques.
Igarashi T, Donau O, Imamichi H, Nishimura Y, Theodore T, Iyengar R
J Virol. 2007; 81(19):10669-79.
PMID: 17626082
PMC: 2045473.
DOI: 10.1128/JVI.00517-07.
A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.
Mealey R, Lee J, Leib S, Littke M, McGuire T
J Immunol. 2006; 177(10):7377-90.
PMID: 17082657
PMC: 3342702.
DOI: 10.4049/jimmunol.177.10.7377.
Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.
Chung C, Mealey R, McGuire T
Virology. 2005; 342(2):228-39.
PMID: 16139857
PMC: 3348724.
DOI: 10.1016/j.virol.2005.07.033.
A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus.
Zhang B, Jin S, Jin J, Li F, Montelaro R
Proc Natl Acad Sci U S A. 2005; 102(28):9918-23.
PMID: 15985554
PMC: 1174982.
DOI: 10.1073/pnas.0501560102.
Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.
Mealey R, Sharif A, Ellis S, Littke M, Leib S, McGuire T
Virology. 2005; 339(1):110-26.
PMID: 15979679
PMC: 3342685.
DOI: 10.1016/j.virol.2005.05.025.
Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.
Jin S, Issel C, Montelaro R
Clin Diagn Lab Immunol. 2004; 11(6):1120-9.
PMID: 15539516
PMC: 524783.
DOI: 10.1128/CDLI.11.6.1120-1129.2004.
CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.
Chung C, Mealey R, McGuire T
Virology. 2004; 327(1):144-54.
PMID: 15327905
PMC: 3342308.
DOI: 10.1016/j.virol.2004.06.035.
Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.
Mealey R, Leib S, Pownder S, McGuire T
J Virol. 2004; 78(17):9295-305.
PMID: 15308724
PMC: 506964.
DOI: 10.1128/JVI.78.17.9295-9305.2004.
Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.
Payne S, Pei X, Jia B, Fagerness A, Fuller F
J Virol. 2004; 78(5):2478-85.
PMID: 14963146
PMC: 369206.
DOI: 10.1128/jvi.78.5.2478-2485.2004.
Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.
Mealey R, Zhang B, Leib S, Littke M, McGuire T
Virology. 2003; 313(2):537-52.
PMID: 12954220
PMC: 3342690.
DOI: 10.1016/s0042-6822(03)00344-1.
Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
Liou L, Herrmann C, Rice A
J Virol. 2002; 76(21):10579-87.
PMID: 12368300
PMC: 136632.
DOI: 10.1128/jvi.76.21.10579-10587.2002.